FAKTOR-OPTIONSSCHEIN - BAYER | Delayed Deutsche Boerse AG 09:13:32 2024-06-05 EDT | ||
| 0.16 EUR | -5.88% |
|
| Current month | -5.56% | ||
| 1 month | -22.73% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BAYER AG
| Date | Price | Change |
|---|---|---|
| 24-06-05 | 0.16 | -5.88% |
| 24-06-04 | 0.17 | 0.00% |
| 24-06-03 | 0.17 | -5.56% |
| 24-05-31 | 0.18 | -5.26% |
| 24-05-30 | 0.19 | -26.92% |
Delayed Quote Deutsche Boerse AG
Last update June 05, 2024 at 09:13 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BAYER AG |
| Issuer | 
Société Générale
|
| WKN | SD23PU |
| ISIN | DE000SD23PU9 |
| Date issued | 2021-01-20 |
| Strike | 52.76 € |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 9.91 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.53 € |
|---|---|
| Lowest since issue | 0.006 € |
| Spread | 0.01 € |
| Spread % | 5.88% |
Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
-
Consensus: Bayer AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
28.34
EUR
Average target price
36.64
EUR
Spread / Average Target
+29.30%
- Stock Market
- Certificates
- Certificat
